Recalls / Active ingredient / Aprepitant
Aprepitant
2 FDA drug recalls involving the active ingredient “Aprepitant”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-12-12 | Class II | Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe | Merck Sharp & Dohme LLC |
| 2022-04-13 | Class II | Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06 | Mckesson Medical-Surgical Inc. Corporate Office |